Literature DB >> 4583777

Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.

B Myrvang, T Godal, D S Ridley, S S Fröland, Y K Song.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4583777      PMCID： PMC1553815     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  25 in total

1.  Enhancing effect of antilymphocytic globulin on human leprosy infection in thymectomized mice.

Authors:  J M Gaugas
Journal:  Nature       Date:  1968-12-21       Impact factor: 49.962

2.  Demonstration of rheumatoid factor in tissue by mixed agglutination with tissue sections.

Authors:  E J Milde; O Tönder
Journal:  Arthritis Rheum       Date:  1968-08

3.  Experimental lepromatous leprosy.

Authors:  R J Rees; M F Waters; A G Weddell; E Palmer
Journal:  Nature       Date:  1967-08-05       Impact factor: 49.962

4.  Significance of variations within the lepromatous group.

Authors:  D S Ridley; M F Waters
Journal:  Lepr Rev       Date:  1969-07       Impact factor: 0.537

5.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

6.  Human lymphocyte migration as a parameter of hypersensitivity.

Authors:  M Soborg; G Bendixen
Journal:  Acta Med Scand       Date:  1967-02

7.  Human leprosy in normal mice.

Authors:  R J Rees; A G Weddell; E Palmer; J M Pearson
Journal:  Br Med J       Date:  1969-07-26

8.  In vitro detection of cellular hypersensitivity in man. Specific migration inhibition of white blood cells from brucella-positive persons.

Authors:  M Soborg
Journal:  Acta Med Scand       Date:  1967-08

9.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

10.  The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis.

Authors:  R A Lerner; R J Glassock; F J Dixon
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307
View more
  72 in total

1.  The potentiating, mitogenic and inhibitory effects on lymphocytes in vitro, of macrophages in the lymph nodes of mice 'overloaded' with mycobacterial products.

Authors:  G A Rook
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

2.  Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.

Authors:  R Melsom; M Harboe; B Myrvang; T Godal; A Belehu
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

3.  Thymus-dependent lymphocytes in leprosy. II. Effect of chemotherapy on T-lymphocyte subpopulations.

Authors:  R N Mshana; A Haregewoin; A Belehu
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

4.  Leprosy patients with lepromatous disease recognize cross-reactive T cell epitopes in the Mycobacterium leprae 10-kD antigen.

Authors:  R Hussain; H M Dockrell; F Shahid; S Zafar; T J Chiang
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

5.  Suppression of the antibody response to sulfolipids in leprosy patients by 4,4'-diaminodiphenyl sulfone (DDS).

Authors:  U Malik; G K Khuller; B Kumar
Journal:  Antonie Van Leeuwenhoek       Date:  1983-12       Impact factor: 2.271

6.  In vitro suppression of interleukin 2 production by Mycobacterium leprae antigen.

Authors:  S Makonkawkeyoon; W Kasinrerk
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

7.  The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues.

Authors:  A Rambukkana; J D Burggraaf; W R Faber; M Harboe; P Teeling; S Krieg; P K Das
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Amyloid-related serum component (protein ASC) IN LEPROSY PATIENTS.

Authors:  G Kronvall; G Husby; D Samuel; G Bjune; H Wheate
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

9.  Experimental lepromatous leprosy in the white-handed gibbon (Hylobatus lar): successful inoculation with leprosy bacilli of human origin.

Authors:  M F Waters; I B Bakri; H J Isa; R J Rees; A C McDougall
Journal:  Br J Exp Pathol       Date:  1978-12

10.  Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae.

Authors:  H K Gill; A S Mustafa; T Godal
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.